Literature DB >> 16880069

New insights and directions in travelers' diarrhea.

Herbert L DuPont1.   

Abstract

Since first studied more than 5 decades ago the risk of travelers'diarrhea for persons going from industrialized regions to developing countries has remained high. Most cases of illness are caused by bacterial agents. Travelers' diarrhea is associated with temporary disability and it may progress to chronic intestinal illness and postinfectious irritable bowel syndrome. Exercising care about food and beverage intake, the use of rifaximin prophylaxis for selective patients, and self-treatment of all resultant illness will continue to be the way in which the disease is prevented or managed best by travelers. Future approaches will be aimed at making host regions safer and providing more effective methods of treatment and prevention of enteric disease during short-term international travel.

Entities:  

Mesh:

Year:  2006        PMID: 16880069     DOI: 10.1016/j.gtc.2006.03.008

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  9 in total

1.  Diarrhoeal episodes in travellers suffering from IBD.

Authors:  Pierre Ellul; Valerie Anne Fenech; Christine Azzopardi; Lara Callus; Nicholas Delicata; Jeffrey Muscat; Neville Azzopardi; Mario Vassallo
Journal:  Frontline Gastroenterol       Date:  2012-12-14

2.  In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008.

Authors:  Jeannette Ouyang-Latimer; Syed Jafri; Audrey VanTassel; Zhi-Dong Jiang; Kaur Gurleen; Savio Rodriguez; Ranjan K Nandy; Thandavaryan Ramamurthy; Santanu Chatterjee; Robin McKenzie; Robert Steffen; Herbert L DuPont
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

3.  ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults.

Authors:  Mark S Riddle; Herbert L DuPont; Bradley A Connor
Journal:  Am J Gastroenterol       Date:  2016-04-12       Impact factor: 10.864

4.  Serum antibodies protect against intraperitoneal challenge with enterotoxigenic Escherichia coli.

Authors:  Xinghong Yang; Theresa Thornburg; Kathryn Holderness; Zhiyong Suo; Ling Cao; Timothy Lim; Recep Avci; David W Pascual
Journal:  J Biomed Biotechnol       Date:  2011-10-09

Review 5.  Immunization in travel medicine.

Authors:  Suzanne Moore Shepherd; William Hudson Shoff
Journal:  Prim Care       Date:  2011-12       Impact factor: 2.907

Review 6.  Colonization with extended-spectrum beta-lactamase-producing Escherichia coli and traveler's diarrhea attack rates among travelers to India: a systematic review and meta-analysis.

Authors:  Basilua Andre Muzembo; Kei Kitahara; Ayumu Ohno; Keinosuke Okamoto; Shin-Ichi Miyoshi
Journal:  Trop Dis Travel Med Vaccines       Date:  2022-10-01

Review 7.  Diagnosis and treatment of acute or persistent diarrhea.

Authors:  Sean W Pawlowski; Cirle Alcantara Warren; Richard Guerrant
Journal:  Gastroenterology       Date:  2009-05-07       Impact factor: 22.682

8.  The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea.

Authors:  Hoonmo L Koo; Herbert L Dupont; David B Huang
Journal:  Ther Clin Risk Manag       Date:  2009-11-02       Impact factor: 2.423

Review 9.  Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis.

Authors:  Sanjin Alajbegovic; John W Sanders; Deborah E Atherly; Mark S Riddle
Journal:  Syst Rev       Date:  2012-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.